Femasys (FEMY) Cash from Operations Growth (1y) (2021 - 2026)
Femasys (FEMY) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.72 Bn | 121.51 Bn | 1.96 Bn | 48.31% |
| 2 | Becton Dickinson | 44.88 Bn | 44.07 Bn | 2.15 Bn | 428.92% |
| 3 | Alcon | 33.19 Bn | 31.53 Bn | 1.53 Bn | - |
| 4 | Medline | 32.91 Bn | 30.67 Bn | 1.84 Bn | -39.59% |
| 5 | Resmed | 29.46 Bn | 27.80 Bn | 890.98 Mn | -4.24% |
| 6 | West Pharmaceutical Services | 23.22 Bn | 22.79 Bn | 329.20 Mn | -29.98% |
| 7 | Solventum | 14.06 Bn | 13.50 Bn | 1.10 Bn | -751.72% |
| 8 | Cooper Companies | 13.85 Bn | 13.71 Bn | 735.40 Mn | 90.02% |
| 9 | Align Technology | 12.13 Bn | 11.07 Bn | 736.59 Mn | 186.74% |
| 10 | Femasys | 14.65 Mn | 9.27 Mn | - | 13.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.05% |
| Dec 31, 2025 | 17.53% |
| Sep 30, 2025 | 1.59% |
| Jun 30, 2025 | -0.60% |
| Mar 31, 2025 | -4.31% |
| Dec 31, 2024 | -67.15% |
| Sep 30, 2024 | -91.71% |
| Jun 30, 2024 | -57.84% |
| Mar 31, 2024 | -72.54% |
| Dec 31, 2023 | -5.86% |
| Sep 30, 2023 | -4.60% |
| Jun 30, 2023 | -15.18% |
| Mar 31, 2023 | 3.86% |
| Dec 31, 2022 | -27.58% |
| Sep 30, 2022 | -51.55% |
| Jun 30, 2022 | 12.53% |
| Mar 31, 2022 | -137.28% |
| Dec 31, 2021 | -76.86% |
| Sep 30, 2021 | -109.71% |